CORT icon

Corcept Therapeutics
CORT

Overview Fund Activity

52 hedge funds and large institutions have $108M invested in Corcept Therapeutics in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
16
Reduced
16
Closed
6
Calls
$66K
Puts
–
Net Calls
+$66K
Net Calls Change
-$43K

Top Buyers

1
BFA
1
BlackRock Fund Advisors
California
$4.48M
2
MC
2
Menta Capital
California
$389K
3
ISL
3
Ingalls & Snyder LLC
New York
$21.6M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.61M
5
SIM
5
Spark Investment Management
New York
$170K

Top Sellers

1
CCA
1
Catalyst Capital Advisors
New York
$0
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$39.6M
3
TC
3
TFS Capital
Pennsylvania
$0
4
SB
4
Suntrust Banks
Georgia
$216K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.26M
Name Holding Trade Value Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$124 +$4 +1,435 +4%
CCA
52
Catalyst Capital Advisors
New York
– -$1.45M -540,000 Closed
TC
53
TFS Capital
Pennsylvania
– -$134K -49,868 Closed
SG Americas Securities
54
SG Americas Securities
New York
– -$76K -28,419 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$20K -7,456 Closed
Envestnet Asset Management
56
Envestnet Asset Management
Illinois
– -$9K -3,500 Closed
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
– -$8.34K -3,112 Closed
1 2
3